Intrathecal rituximab for EBV-associated post-transplant lymphoproliferative disorder with central nervous system involvement unresponsive to intravenous rituximab-based treatments: a prospective study.

Intrathecal rituximab for EBV-associated post-transplant lymphoproliferative disorder with central nervous system involvement unresponsive to intravenous rituximab-based treatments: a prospective study.

Item

http://www.wikidata.org/entity/Q50935631

Q50935631

about

Biology of CNS lymphoma and the potential of novel agents.

P2860

Q45985951-455BB905-4911-4B8C-BC4B-8437DA6EB294

P2860

Intrathecal rituximab for EBV-associated post-transplant lymphoproliferative disorder with central nervous system involvement unresponsive to intravenous rituximab-based treatments: a prospective study.

Item

http://www.wikidata.org/entity/Q50935631

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Intrathecal rituximab for EBV- ...... eatments: a prospective study.

@en

Intrathecal rituximab for EBV- ...... eatments: a prospective study.

@nl

type

Item

label

Intrathecal rituximab for EBV- ...... eatments: a prospective study.

@en

Intrathecal rituximab for EBV- ...... eatments: a prospective study.

@nl

prefLabel

Intrathecal rituximab for EBV- ...... eatments: a prospective study.

@en

Intrathecal rituximab for EBV- ...... eatments: a prospective study.

@nl

P1476

Intrathecal rituximab for EBV- ...... eatments: a prospective study.

@en

P2093

F Huang

http://www.w3.org/2001/XMLSchema#string

G Yu

http://www.w3.org/2001/XMLSchema#string

H Zhou

http://www.w3.org/2001/XMLSchema#string

J Sun

http://www.w3.org/2001/XMLSchema#string

L Xuan

http://www.w3.org/2001/XMLSchema#string

M Dai

http://www.w3.org/2001/XMLSchema#string

M Wu

http://www.w3.org/2001/XMLSchema#string

Q Liu

http://www.w3.org/2001/XMLSchema#string

R Feng

http://www.w3.org/2001/XMLSchema#string

X Guo

http://www.w3.org/2001/XMLSchema#string

P2860

Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group Report.

Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era.

Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in high-risk patients.

Posttransplant lymphoproliferative disorder: significance of central nervous system involvement.

Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.

Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation: results of a phase II trial.

Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation.

Post transplant lymphoproliferative disorders: risk, classification, and therapeutic recommendations.

Spectrum of Epstein-Barr virus-associated diseases in recipients of allogeneic hematopoietic stem cell transplantation.

EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era.

P2888

bmt.2015.281

P304

456-458

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2015.281

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26595071

http://www.w3.org/2001/XMLSchema#string

P921

Post-transplant lymphoproliferative disorder

Intrathecal rituximab for EBV-associated post-transplant lymphoproliferative disorder with central nervous system involvement unresponsive to intravenous rituximab-based treatments: a prospective study.

about

P2860

P2860

Intrathecal rituximab for EBV-associated post-transplant lymphoproliferative disorder with central nervous system involvement unresponsive to intravenous rituximab-based treatments: a prospective study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P921